Salmonellosis outcomes differ substantially by serotype.

BACKGROUND Most human infections are caused by closely related serotypes within 1 species of Salmonella. Few data are available on differences in severity of disease among common serotypes. METHODS We examined data from all cases of Salmonella infection in FoodNet states during 1996-2006. Data included serotype, specimen source, hospitalization, and outcome. RESULTS Among 46,639 cases, 687 serotypes were identified. Overall, 41,624 isolates (89%) were from stool specimens, 2524 (5%) were from blood, and 1669 (4%) were from urine; 10,393 (22%) cases required hospitalization, and death occurred in 219 (0.5%). The case fatality rate for S. Newport (0.3%) was significantly lower than for Typhimurium (0.6%); Dublin (3.0%) was higher. With respect to invasive disease, 13 serotypes had a significantly higher proportion than Typhimurium (6%), including Enteritidis (7%), Heidelberg (13%), Choleraesuis (57%), and Dublin (64%); 13 serotypes were significantly less likely to be invasive. Twelve serotypes, including Enteritidis (21%) and Javiana (21%), were less likely to cause hospitalization than Typhimurium (24%); Choleraesuis (60%) was significantly more so. CONCLUSIONS Salmonella serotypes are closely related genetically yet differ significantly in their pathogenic potentials. Understanding the mechanisms responsible for this may be key to a more general understanding of the invasiveness of intestinal bacterial infections.

[1]  Deborah A. Adams,et al.  Summary of notifiable diseases --- United States, 2005. , 2007, MMWR. Morbidity and mortality weekly report.

[2]  K. Mølbak Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  T. Barrett,et al.  Hospitalization and Antimicrobial Resistance in Salmonella Outbreaks, 1984–2002 , 2005, Emerging infectious diseases.

[4]  T. Jones,et al.  Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. , 2005, The Journal of infectious diseases.

[5]  K. Mølbak,et al.  Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. , 2004, The Journal of infectious diseases.

[6]  Matthew R Moore,et al.  Surveillance for sporadic foodborne disease in the 21st century: the FoodNet perspective. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  P. Cieslak,et al.  FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  R. Guerrant,et al.  Clinical practice. Acute infectious diarrhea. , 2004, The New England journal of medicine.

[9]  R. Guerrant,et al.  Acute Infectious Diarrhea , 2004 .

[10]  L B Reller,et al.  Practice guidelines for the management of infectious diarrhea. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Diagnosis and management of foodborne illnesses: a primer for physicians. , 2001, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[12]  F. W. Brenner,et al.  Salmonella Nomenclature , 2000, Journal of Clinical Microbiology.

[13]  M. Harper,et al.  Non-typhi Salmonella bacteremia in children. , 1999, The Pediatric infectious disease journal.

[14]  L. Leibovici,et al.  Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Samuel L. Groseclose,et al.  Summary of Notifiable Diseases, United States. , 1997 .

[16]  J. W. Bass,et al.  Nontyphoidal Salmonella enteric infections and bacteremia , 1989, The Pediatric infectious disease journal.

[17]  S. Lolekha,et al.  Predictors for extraintestinal infection in Salmonella enteritis in Thailand , 1988, The Pediatric infectious disease journal.

[18]  R. Feldman,et al.  From the centers for disease control. Salmonella bacteremia: reports to the Centers for Disease Control, 1968-1979. , 1981, The Journal of infectious diseases.

[19]  H. Neu,et al.  SEPTICEMIA WITH NON-TYPHOID SALMONELLA , 1974, Medicine.

[20]  T. Fodor,et al.  Symptoms, septicemia and death in salmonellosis. , 1969, American journal of epidemiology.

[21]  M. Swartz,et al.  Salmonellosis--a review of some unusual aspects. , 1960, The New England journal of medicine.

[22]  J. P. Reardon,et al.  Salmonellosis in Massachusetts; a sixteen-year experience. , 1957, The New England journal of medicine.

[23]  J. Winter,et al.  Clinical manifestations of salmonellosis in man; an evaluation of 7779 human infections identified at the New York Salmonella Center. , 1957, The New England journal of medicine.

[24]  I. Saphra,et al.  SALMONELLA CHOLERAE SUIS. A CLINICAL AND EPIDEMIOLOGICAL EVALUATION OF 329 INFECTIONS IDENTIFIED BETWEEN 1940 AND 1954 IN THE NEW YORK SALMONELLA CENTER , 1954, The American journal of the medical sciences.

[25]  E. Seligmann,et al.  Salmonella infections in the U.S.A.; a second series of 2,000 human infections recorded by the N.Y. Salmonella Center. , 1946, Journal of immunology.

[26]  E. Seligmann,et al.  SALMONELLA INFECTIONS IN MANAN ANALYSIS OF 1,000 CASES BACTERIOLOGICALLY IDENTIFIED BY THE NEW YORK SALMONELLA CENTER , 1943 .